KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 93 filers reported holding KALVISTA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $96 | +1820.0% | 9,959 | +1860.4% | 0.00% | – |
| Q2 2023 | $5 | -94.0% | 508 | -95.2% | 0.00% | – |
| Q1 2023 | $83 | -26.5% | 10,608 | -36.8% | 0.00% | – |
| Q4 2022 | $113 | -100.0% | 16,787 | -0.2% | 0.00% | – |
| Q3 2022 | $244,000 | +47.9% | 16,819 | +0.4% | 0.00% | – |
| Q2 2022 | $165,000 | -33.5% | 16,755 | -0.3% | 0.00% | – |
| Q1 2022 | $248,000 | +47.6% | 16,810 | +32.7% | 0.00% | – |
| Q4 2021 | $168,000 | -51.7% | 12,663 | -36.5% | 0.00% | – |
| Q3 2021 | $348,000 | -64.7% | 19,947 | -51.5% | 0.00% | -100.0% |
| Q2 2021 | $985,000 | +13.9% | 41,096 | +22.1% | 0.00% | 0.0% |
| Q1 2021 | $865,000 | +279.4% | 33,659 | +180.5% | 0.00% | – |
| Q4 2020 | $228,000 | +51.0% | 12,000 | 0.0% | 0.00% | – |
| Q3 2020 | $151,000 | +4.1% | 12,000 | 0.0% | 0.00% | – |
| Q2 2020 | $145,000 | +57.6% | 12,000 | 0.0% | 0.00% | – |
| Q1 2020 | $92,000 | -57.0% | 12,000 | 0.0% | 0.00% | – |
| Q4 2019 | $214,000 | +54.0% | 12,000 | 0.0% | 0.00% | – |
| Q3 2019 | $139,000 | -47.7% | 12,000 | 0.0% | 0.00% | – |
| Q2 2019 | $266,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,719,576 | $38,088,000 | 25.57% |
| VHCP Management III, LLC | 637,884 | $14,129,000 | 6.60% |
| Vivo Capital, LLC | 1,359,149 | $30,105,000 | 2.82% |
| INTERWEST VENTURE MANAGEMENT CO | 388,766 | $8,611,000 | 2.78% |
| VHCP Management II, LLC | 376,889 | $8,348,000 | 2.63% |
| Samsara BioCapital, LLC | 118,500 | $2,625,000 | 1.73% |
| ACUTA CAPITAL PARTNERS, LLC | 213,000 | $4,718,000 | 1.68% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 187,599 | $4,165,000 | 1.54% |
| Ghost Tree Capital, LLC | 300,000 | $6,645,000 | 1.38% |
| Eventide Asset Management | 1,500,000 | $33,225,000 | 1.01% |